ICS Global Limited, an investment holding company, provides medical billing services primarily in the United Kingdom. More Details
Flawless balance sheet with solid track record.
Share Price & News
How has ICS Global's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: Insufficient data to determine ICS's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine ICS's volatility change over the past year.
7 Day Return
1 Year Return
Return vs Industry: ICS exceeded the Australian Healthcare industry which returned 20.1% over the past year.
Return vs Market: ICS underperformed the Australian Market which returned 26.9% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is ICS Global's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StTrade Alert: Damian Banks At ICS Global Limited (ASX:ICS), Has Just Spent AU$1.3m Buying A Small Number of Shares
3 months ago | Simply Wall StHas ICS Global Limited (ASX:ICS) Stock's Recent Performance Got Anything to Do With Its Financial Health?
5 months ago | Simply Wall StShould You Buy ICS Global Limited (ASX:ICS) For Its Dividend?
Is ICS Global undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ICS (A$2.19) is trading below our estimate of fair value (A$23.63)
Significantly Below Fair Value: ICS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ICS is good value based on its PE Ratio (19.7x) compared to the Australian Healthcare industry average (21x).
PE vs Market: ICS is good value based on its PE Ratio (19.7x) compared to the Australian market (20x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate ICS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: ICS is overvalued based on its PB Ratio (3.5x) compared to the AU Healthcare industry average (1.8x).
How is ICS Global forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ICS Global has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has ICS Global performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ICS has high quality earnings.
Growing Profit Margin: ICS's current net profit margins (19.3%) are higher than last year (14.7%).
Past Earnings Growth Analysis
Earnings Trend: ICS's earnings have grown by 1.7% per year over the past 5 years.
Accelerating Growth: ICS's earnings growth over the past year (166.5%) exceeds its 5-year average (1.7% per year).
Earnings vs Industry: ICS earnings growth over the past year (166.5%) exceeded the Healthcare industry 25.5%.
Return on Equity
High ROE: ICS's Return on Equity (17.8%) is considered low.
How is ICS Global's financial position?
Financial Position Analysis
Short Term Liabilities: ICS's short term assets (A$10.3M) exceed its short term liabilities (A$4.0M).
Long Term Liabilities: ICS has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ICS is debt free.
Reducing Debt: ICS had no debt 5 years ago.
Debt Coverage: ICS has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ICS has no debt, therefore coverage of interest payments is not a concern.
What is ICS Global current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ICS's dividend (1.83%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (1.96%).
High Dividend: ICS's dividend (1.83%) is low compared to the top 25% of dividend payers in the Australian market (4.9%).
Stability and Growth of Payments
Stable Dividend: ICS has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: ICS's dividend payments have increased, but the company has only paid a dividend for 9 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (40.6%), ICS's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
ICS Global has no CEO, or we have no data on them.
Experienced Board: ICS's board of directors are seasoned and experienced ( 11 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ICS insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
ICS Global Limited's company bio, employee growth, exchange listings and data sources
- Name: ICS Global Limited
- Ticker: ICS
- Exchange: ASX
- Founded: 1999
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: AU$23.223m
- Shares outstanding: 10.60m
- Website: https://icsglobal.com.au
- ICS Global Limited
- PO Box R1821
- Royal Exchange
- New South Wales
ICS Global Limited, an investment holding company, provides medical billing services primarily in the United Kingdom. The company offers medical billing and collection services to medical consultants and s...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/28 08:26|
|End of Day Share Price||2021/06/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.